Lethal somatostatin analog-induced acute necrotizing pancreatitis in a patient with hormone-refractory prostate cancer.
We report a fatal case of acute pancreatitis which developed in a 76-year-old male with hormone-refractory prostatic carcinoma who was being treated with lanreotide, a slow-release somatostatin analog.